Most patients receiving a GLP-1 receptor agonist (RA) and a biologic continue co-therapy for over a year with few treatment-related adverse events.

Amjevita (adalimumab-atto) is a prescription drug used for certain inflammatory conditions, including rheumatoid arthritis and ulcerative colitis. Amjevita can cause side effects that range from mild ...

Please provide your email address to receive an email when new articles are posted on . Persistence was defined as a lack of a treatment gap of more than two doses, with more than half of refills ...